161 related articles for article (PubMed ID: 21468523)
21. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
22. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
23. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
[TBL] [Abstract][Full Text] [Related]
24. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of TP53 alterations in adrenocortical carcinomas.
Waldmann J; Patsalis N; Fendrich V; Langer P; Saeger W; Chaloupka B; Ramaswamy A; Fassnacht M; Bartsch DK; Slater EP
Langenbecks Arch Surg; 2012 Feb; 397(2):209-16. PubMed ID: 22203015
[TBL] [Abstract][Full Text] [Related]
26. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
27. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
Gaujoux S; Hantel C; Launay P; Bonnet S; Perlemoine K; Lefèvre L; Guillaud-Bataille M; Beuschlein F; Tissier F; Bertherat J; Rizk-Rabin M; Ragazzon B
PLoS One; 2013; 8(2):e55743. PubMed ID: 23409032
[TBL] [Abstract][Full Text] [Related]
28. An Activating Variant in CTNNB1 is Associated with a Sclerosing Bone Dysplasia and Adrenocortical Neoplasia.
Peng H; Jenkins ZA; White R; Connors S; Hunter MF; Ronan A; Zankl A; Markie DM; Daniel PB; Robertson SP
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31970420
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
[TBL] [Abstract][Full Text] [Related]
30. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
31. Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon B; Libé R; Assié G; Tissier F; Barreau O; Houdayer C; Perlemoine K; Audebourg A; Clauser E; René-Corail F; Bertagna X; Dousset B; Bertherat J; Groussin L
Eur J Endocrinol; 2014 Mar; 170(3):385-91. PubMed ID: 24347427
[TBL] [Abstract][Full Text] [Related]
32. Germline p53 mutation in a Micronesian child with adrenocortical carcinoma and subsequent osteosarcoma.
Delaney HM; Prauner RD; Person DA
J Pediatr Hematol Oncol; 2008 Nov; 30(11):803-6. PubMed ID: 18989156
[TBL] [Abstract][Full Text] [Related]
33. Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors.
Masi G; Lavezzo E; Iacobone M; Favia G; Palù G; Barzon L
J Endocrinol Invest; 2009 Jul; 32(7):597-600. PubMed ID: 19498322
[TBL] [Abstract][Full Text] [Related]
34. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
35. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific mutations in p53: the acid test.
Hainaut P
Nat Med; 2002 Jan; 8(1):21-3. PubMed ID: 11786899
[No Abstract] [Full Text] [Related]
37. Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours.
Mermejo LM; Leal LF; Colli LM; Fragoso MC; Latronico AC; Tone LG; Scrideli CA; Tucci S; Martinelli CE; Yunes JA; Mastellaro MJ; Seidinger AL; Brandalise SR; Moreira AC; Ramalho LN; Antonini SR; Castro M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):503-10. PubMed ID: 24717047
[TBL] [Abstract][Full Text] [Related]
38. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.
Heaton JH; Wood MA; Kim AC; Lima LO; Barlaskar FM; Almeida MQ; Fragoso MC; Kuick R; Lerario AM; Simon DP; Soares IC; Starnes E; Thomas DG; Latronico AC; Giordano TJ; Hammer GD
Am J Pathol; 2012 Sep; 181(3):1017-33. PubMed ID: 22800756
[TBL] [Abstract][Full Text] [Related]
39. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors.
Pinto EM; Billerbeck AE; Villares MC; Domenice S; Mendonça BB; Latronico AC
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):647-50. PubMed ID: 15761534
[TBL] [Abstract][Full Text] [Related]
40. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
